Delivery Order SPE2DX22D0030-SPE2D826F0CD8

AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,572.48 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025. This firm fixed price delivery order, with an ultimate completion date of December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, reflecting the vendor's demonstrated capability to meet federal procurement requirements for pharmaceutical and medical supply needs.

This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support vehicle that enables the company to supply a broad range of medications, vaccines, and medical devices to support military healthcare programs globally. The parent contract with DLA Troop Support Medical serves multiple government healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical vendor within the federal medical procurement supply chain. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices.